TransMedics Group, Inc. Debt Securities, Available-for-sale, Allowance for Credit Loss, Period Increase (Decrease)
TransMedics Group, Inc. (TMDX) reported Debt Securities, Available-for-sale, Allowance for Credit Loss, Period Increase (Decrease) of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-27.
Discontinued › Notes › Credit Losses
us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease · last filed 2023-02-27
- TransMedics Group, Inc. debt securities, available-for-sale, allowance for credit loss, period increase (decrease) for fiscal 2022 was $0.00.
- TransMedics Group, Inc. debt securities, available-for-sale, allowance for credit loss, period increase (decrease) for fiscal 2021 was $0.00.
- TransMedics Group, Inc. debt securities, available-for-sale, allowance for credit loss, period increase (decrease) for fiscal 2020 was $0.00.
| Period end | Debt Securities, Available-for-sale, Allowance for Credit Loss, Period Increase (Decrease) 12 month |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-27 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-27 |
| 2020-12-31 | $0.00 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |